drugset / Trial / NCT00621998

Risperidone and Olanzapine for the Schizophrenic Patients With Neuroleptic-Induced Tardive Dyskinesia

NCT00621998

RandomizedParallel-groupSingle-blindTreatment

Summary

We initiate a study with research grant from department of health and Taoyuan mental hospital and choose risperidone and olanzapine as study medications. We compare the effects of these 2 drugs in schizophrenic spectrum patients of Han ethnics with neuroleptic-induced tardive dyskinesia to test the hypothesis that these two medications have different effects in improving tardive dyskinesia.

Timeline

Start
2000-07
Primary completion
2003-12
Completion
2004-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Olanzapine Small molecule
Comparator Risperidone Other / unclassified

Indications